Research Article
Evaluation of the Antimicrobial Properties of the Essential Oil of Myrtus communis L. against Clinical Strains of Mycobacterium spp.
Table 1
Activity of antitubercular drugs and Myrtus communis against Mycobacterium tuberculosis strains.
| | Strains | MIC | Antitubercular Drug* | | M. tuberculosis | Myrtus communis % (v/v) | SM | INH | RIF | ETH | PZA | CLA | CIP |
| | H37Rv | 0.17% | S | S | S | S | — | — | — | | H37Ra | 0.17% | S | S | S | S | — | — | — | | M. tuberculosis | 0.17% | S | S | R | S | — | — | — | | M. tuberculosis | 0.17% | S | S | R | S | — | — | — | | M. tuberculosis | 0.17% | S | R | R | S | — | — | — | | M. tuberculosis | 0.17% | R | S | R | S | — | — | — | | M. tuberculosis | 0.17% | R | R | S | S | — | — | — | | M. tuberculosis | 0.17% | R | R | S | R | — | — | — | | M. tuberculosis | 0.17% | R | R | R | S | R | R | R | | M. tuberculosis | 0.17% | S | S | S | S | — | — | — | | M. paratuberculosis (1515) | 2% | — | — | — | — | — | — | — | | M. paratuberculosis (1517) | 2% | — | — | — | — | — | — | — |
|
|
*SM: streptomicin; INH: isoniazid; RIF: rifampicin; ETH: ethambutol; PZA: pyrazinamide; CLA: clarithromycin; CIP: ciprofloxacin.
|
